Scipher Medicine Closes $110M Financing Round
Summary
Tim Anderson, partner and head of Research at Cowen Healthcare Investments, is joining Scipher’s Board of Directors. Led by Alif Saleh, chief executive officer, Scipher is a precision immunology company matching patients with their most effective therapy. Using Spectra™, its proprietary network medicine platform, the company commercializes tests revealing a person’s unique molecular disease signature and match it to the most effective therapy, ensuring optimal treatment from day one. The patient molecular data generated from the tests further supports the discovery and development of novel and more effective therapeutics. Scipher partners with leading payers, health care providers, and pharmaceutical companies to bring solutions to patients with autoimmune diseases.